
Category: Healthcare
-

Date:
Beta Blockers Market to Reach USD 14.4 Billion by 2031 as Demand Grows for Chronic Heart Disease Management
The global beta blockers market continues to witness steady growth, supported by the increasing prevalence of cardiovascular diseases (CVDs), rising geriatric population,…
-

Date:
Penicillin G Acylase Market to Surpass US$ 1.1 Billion by 2031 Driven by Rising Demand for Semi-Synthetic Antibiotics
The global penicillin G acylase market is witnessing steady growth, supported by increasing demand for semi-synthetic antibiotics and advancements in biocatalysis technologies.…
-

Date:
Severe Acute Respiratory Syndrome Treatment Market Size Forecast to USD 8.6 Billion by 2031 amid Declining Demand Post-Pandemic – Analysis by Transparency Market Research
Severe Acute Respiratory Syndrome Treatment Market Outlook 2031 The global severe acute respiratory syndrome (SARS) treatment market was valued at US$ 24.6…
-

Date:
Neonatal Respiratory Distress Syndrome Treatment Market Expected to Surpass USD 1.6 Billion by 2031 Amid Rising Premature Birth Rates and Advancements in Neonatal Care
The global Neonatal Respiratory Distress Syndrome (NRDS) Treatment Market is experiencing steady and meaningful expansion, driven by rising cases of premature births,…
-

Date:
Pediatric Asthma Treatment Market to Reach USD 14.4 Bn by 2031 | GSK, AstraZeneca, Novartis, Sanofi Lead Growth
The pediatric asthma treatment market is expected to witness steady growth through 2031, driven by the rising prevalence of asthma among children…
-

Date:
Aldosterone Receptor Antagonists Market to Exceed US$ 4.5 Billion by 2031, Driven by Rising Hypertension and Heart Failure Cases | TMR
Aldosterone Receptor Antagonists Market Overview Aldosterone Receptor Antagonists (ARAs) are a class of drugs used to block the action of aldosterone, a…
-

Date:
Ischemia Reperfusion Injury Therapeutics Market Set to Reach USD 3.2 Billion by 2031 Driven by Rising Cardiovascular Cases
Ischemia reperfusion injury (IRI) is a complex medical condition that occurs when blood flow returns to tissues after a period of oxygen…
-

Date:
Lung Disease Therapeutics Market to Surpass USD 109.4 Bn by 2031, Driven by Innovations from GSK, AstraZeneca, and Novartis
The global lung disease therapeutics market was valued at USD 76.5 billion in 2021 and is projected to surpass USD 109.4 billion…
-
Date:
COVID-19 Therapeutics Market to Decline at -8.3% CAGR Through 2031 — By Drug Class / By Distribution Channel | U.S. • Germany • India • China
The global COVID-19 therapeutics market has undergone a significant transition from rapid expansion during the pandemic peak to a phase of gradual…
Olivia
Carter
is a writer covering health, tech, lifestyle, and economic trends. She loves crafting engaging stories that inform and inspire readers.




